MN gene and protein
AssigneeInstitute of Virology of the Slovak Academy of Sciences
InventorsJan Zavada, Silvia Pastorekova, Jaromir Pastorek
Life of this patent
Estimating the term…
Loading patent…
AssigneeInstitute of Virology of the Slovak Academy of Sciences
InventorsJan Zavada, Silvia Pastorekova, Jaromir Pastorek
Estimating the term…
Herein disclosed is a novel oncogene named MN or alternatively MN/CA IX. Abnormal expression of the MN gene is shown to signify oncogenesis, and diagnostic/prognostic methods for pre-neoplastic/neoplastic disease to detect or detect and quantitate such abnormal MN gene expression. Also disclosed are methods to treat pre-neoplastic/neoplastic disease involving the MN gene and protein, e.g., methods comprising the use of MN-specific antibodies, anti-idiotype antibodies thereto, and anti-anti-idiotype antibodies, and the use of MN antisense nucleic acids. Further disclosed are methods to identify and block MN binding site(s) and identify MN protein partners(s).
A method of inhibiting the growth of a vertebrate preneoplastic or neoplastic cell that is abnormally expressing MN protein comprising contacting that cell with a polypeptide composed of 50 or less amino acids, wherein said polypeptide specifically binds to a site on the MN protein to which vertebrate cells adhere in a cell adhesion assay;
Dependencies are inferred from the claim text.